250
Participants
Start Date
November 30, 2014
Primary Completion Date
March 31, 2019
Study Completion Date
March 31, 2019
Mizoribine (MZR)
Cyclophosphamide (CTX)
Beijing Friendship Hospital, Capital Medical University, Beijing
China-Japan Friendship Hospital, Beijing
Chinese PLA General Hospital, Beijing
Peking University People's Hospital, Beijing
The Third Affiliated Hospital of the Third Military Medical University (Daping Hospital), Chongqing
The first Affiliated Hospital of Fujian Medical University, Fuzhou
Affiliated Hospital of Guilin Medical University, Guilin
The First Affiliated Hospital of Guangxi Medical University, Nanning
The Third Hospital of Hebei Medical University, Shijiazhuang
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Renmin Hospital of Wuhan University, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
Wuxi People's Hospital, Wuxi
The Second Hospital of Jilin University, Changchun
The First Affiliated Hospital of Dalian Medical University, Dalian
The General Hospital of Shenyang Military Region, Shenyang
Shandong Provincial Hospital, Jinan
The General Hospital of Jinan Military Region, Jinan
The Affilited Hospital of Qingdao University, Qingdao
Renji Hospital Shanghai Jiaotong University School of Medical, Shanghai
Zhongshan Hospital Fudan University, Shanghai
The Second Hospital of Shanxi Medical University, Taiyuan
The First Affiliated Hospital of the Fourth Military Medical University (Xijing Hospital), Xian
West China Hospital of Sichuan University, Chengdu
Kuming General Hospital of Chengdu Military Region, Kunming
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
Asahi Kasei Pharma Corporation
INDUSTRY